Credibility Engineering in the Food Industry
Linking Science, Regulation, and Marketing in a Corporate Context
Datos Bibliográficos
| ID | 4516557 |
|---|---|
| Autores | Bart Penders (0000-0002-2661-9181, Radboud University Nijmegen), Annemiek P Nelis, Annemiek Nelis (University of York) |
| Año | 2011 |
| Volumen | 24 |
| Número | 4 |
| Páginas | 487-515 |
| Fecha de publicación | 2011-12-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Science in Context (JOURNAL) |
| Identificadores de la revista | ISSN: 0269-8897 • E-ISSN: 1474-0664 |
| Editorial | Cambridge University Press (CUP) (PUBLISHER) |
| DOI | 10.1017/s0269889711000202 |
| PMID | 22397168 |
| OpenAlex | W1997908347 |
| Idioma | EN |
| Citas recibidas | 14 |
| Referencias citadas | 36 |
ArgumentWe expand upon the notion of the "credibility cycle" through a study of credibility engineering by the food industry. Research and development (R&D) as well as marketing contribute to the credibility of the food company Unilever and its claims. Innovation encompasses the development, marketing, and sales of products. These are directed towards three distinct audiences: scientific peers, regulators, and consumers. R&D uses scientific articles to create credit for itself amongst peers and regulators. These articles are used to support health claims on products. However, R&D, regulation, and marketing are not separate realms. A single strategy of credibility engineering connects health claims to a specific public through linking that public to a health issue and a food product
Argument (complex analysis · Biology · Business · Context (archaeology · Credibility · Health claims on food labels · Political science · Product (mathematics · Chemistry · Global Public Health Policies and Epidemiology · Pharmaceutical industry and healthcare · Risk Perception and Management · Food Science · Marketing
Professional credibility cycles in education
Mythbusters
Media attention to GM food cases
Food, Drugs, and TV
Cool and Safe
Marketing in the Public Sector—Benefits and Barriers
The Precautionary Principle in EU Regulation of GMOs
Dissident Dietary Credibility
Democratising Monograph Publishing or Preying on Researchers? Scholarly Recognition and Global ‘Credibility Economies’
The Political Space between Words and Things
Variants of Epistemic Capitalism
Allonymous science
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘Elsa’ to ‘RRI’
Shifting Expert Configurations and the Public Credibility of Science
Re-Thinking Science
Conflict sociology
Renewing Unilever
Cordelia’s Love
In search of relevance
The governance of sustainable socio-technical transitions
The Social Study of Corporate Science
On the Borderline of Food and Drug
Ghosts in the Machine
Ghosts in the Machine
Organizing Credibility
The Issues Deserve More Credit
Ghosts in the Machine
The Rise of Membrane Technology
Conflict Sociology
Unilever Overseas. The Anatomy of a Multinational
Unilever Overseas
Scientific Communities or Transepistemic Arenas of Research? A Critique of Quasi-Economic Models of Science
How to Kill with a Ballpoint
Patenting Culture in Science
Regulatory objectivity and the generation and management of evidence in medicine
The Scientific Life
Pills, Power, People
The Shifting Engines of Medicalization
| Obras citantes distintas | 14 |
|---|---|
| Citas por año | 0,93 |
| Intervalo de citas | 2011 - 2026 (16) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 14 |